Загрузка...
Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)
Smoking is regarded as a major risk factor for the development of cardiovascular diseases (CVD). This study investigates whether serelaxin (RLX, recombinant human relaxin‐2) endowed with promising therapeutic properties in CVD, can be credited of a protective effect against cigarette smoke (CS)‐indu...
Сохранить в:
| Опубликовано в: : | J Cell Mol Med |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831370/ https://ncbi.nlm.nih.gov/pubmed/26915460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12802 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|